According to Burning Rock Biotech's latest financial reports the company has a price-to-book ratio of 0.7833.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.8784 | -37.98% |
2022-12-31 | 1.42 | -58.83% |
2021-12-31 | 3.44 | -47.12% |
2020-12-31 | 6.51 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
LabCorp LH | 2.23 | 184.19% | ๐บ๐ธ USA |
OpGen
OPGN | 2.17 | 177.00% | ๐บ๐ธ USA |
NeoGenomics
NEO | 2.05 | 161.33% | ๐บ๐ธ USA |